Envíos recentes

Mostrando ítems 1346-1350 de 11841

48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort

2022- Cabello-Ubeda, A.; de Quirós, J.C.L.B.; Carbonero, L.M.; Sanz, J.; Vergas, J.; [et al.]
Prognosis of Paradoxical Low-Flow Low-Gradient Aortic Stenosis: A Severe, Non-critical Form, With Surgical Treatment Benefits

2022- Galian-Gay, L.; Escalona Silva, R.A.; Teixidó-Turà, G.; Casas, G.; Ferrer-Sistach, E.; [et al.]
Survey on the management of Pompe disease in routine clinical practice in Spain

2022- Domínguez-González, C.; Díaz-Marín, C.; Juntas-Morales, R.; Nascimiento-Osorio, A.; Rivera Gallego, Alberto; [et al.]
An umbrella review of the evidence linking oral health and systemic noncommunicable diseases

2022- Botelho, J.; Mascarenhas, P.; Viana, J.; Proença, L.; Orlandi, M.; [et al.]
Novel Phthalazin-1(2H)-One Derivatives Displaying a Dithiocarbamate Moiety as Potential Anticancer Agents

2022- Vila, N.; Besada, Pedro; Brea Floriani, José Manuel; Loza García, María Isabel; Teran Moldes, Carmen [et al.]